Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BE.1.1.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BE.1.1.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-4388.79US
BE.1.1.2ORF1abNIID WH-1 F501R913CTTTACCAGCACGTGCTAGAAGG2352.17896874R-25657.5Japan
BE.1.1.2ORF1abNIID WH-1 F509R854CAGAAGTTGTTATCGACATAGC2240.91837816R-21257.9Japan
BE.1.1.2ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-20165.2Japan
BE.1.1.2SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
BE.1.1.2SNIID WH-1 F24381R24873ATTTGAAACAAAGACACCTTCAC2334.782485624834R-22193.2Japan
BE.1.1.2SNIID WH-1 Seq F24383R24865CAAAGACACCTTCACGAGG1952.632484824830R-20677.6Japan
BN.1.5ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-3635.26China
BN.1.5ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-5250.36France
BN.1.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BN.1.5ORF1abCN-CDC-ORF1abACGATTGTGCATCAGCTGA1947.371346013442R-20306.2China
BN.1.5ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
BN.1.5ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-5057.65Germany
BN.1.5ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-301.668South Korea
BN.1.5ORF1abChan-ORF1abGTGTGATGTTGAWATGACATGGTC2441.671635316330R-13317.5China
BN.1.5ORF1abHKU-ORF1bAACRCGCTTAACAAAGCACTC2142.861890918889R-2518.95Hong Kong
BN.1.5SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R596.957Singapore
BN.1.5SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-3043.11China
BN.1.5SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-1215.87South Korea
BN.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BN.1.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BN.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.5NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
BN.1.5NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-3370.08Thailand
BN.1.5NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-25148.4US
BN.1.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BN.1.5NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
BN.1.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BN.1.5NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BN.1.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BN.1.5NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BN.1.5NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
BN.1.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BN.1.5NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BN.1.5ORF1abNIID WH-1 F501R913CTTTACCAGCACGTGCTAGAAGG2352.17896874R-25657.5Japan
BN.1.5ORF1abNIID WH-1 F509R854CAGAAGTTGTTATCGACATAGC2240.91837816R-21257.9Japan
BN.1.5ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-20165.2Japan
BN.1.5SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
BN.1.5SNIID WH-1 F24381R24873ATTTGAAACAAAGACACCTTCAC2334.782485624834R-22193.2Japan
BN.1.5SNIID WH-1 Seq F24383R24865CAAAGACACCTTCACGAGG1952.632484824830R-20677.6Japan
BF.7ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
BF.7ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-1717.06France
BF.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.7ORF1abCN-CDC-ORF1abACGATTGTGCATCAGCTGA1947.371346013442R-20306.2China
BF.7ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
BF.7ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
BF.7ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
BF.7ORF1abChan-ORF1abGTGTGATGTTGAWATGACATGGTC2441.671635316330R-13317.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used